An FDA advisory panel is reviewing Aimmune’s peanut allergy therapy. Here’s what’s happening

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 13, 2019 at 10:42 AM.

  1. #1 cafead, Sep 13, 2019 at 10:42 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,937
    Likes Received:
    3
    via We’re monitoring today’s meeting of the FDA advisory committee on Palforzia, a novel but controversial treatment that uses calibrated quantities of ingested peanut powder to protect people against severe peanut allergy. Check back here often for updates throughout the day.

    article source
     
    Quote

Reply to Thread